Xanthurenic acid is produced in
**Core Concept**
Xanthurenic acid is a metabolite of tryptophan degradation, which occurs through the kynurenine pathway. This pathway is a crucial part of the body's tryptophan metabolism, and its dysregulation can lead to various clinical manifestations.
**Why the Correct Answer is Right**
The kynurenine pathway is initiated by the enzyme tryptophan 2,3-dioxygenase (TDO) or indoleamine 2,3-dioxygenase (IDO), which catalyzes the conversion of tryptophan to N-formylkynurenine. This is followed by a series of reactions that ultimately lead to the production of xanthurenic acid. Xanthurenic acid is a downstream product of the kynurenine pathway, which is produced through the action of the enzyme 3-hydroxyanthranilic acid oxidase (HAAO).
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a correct location for xanthurenic acid production. While the kynurenine pathway occurs in various tissues, xanthurenic acid is specifically produced in the liver and kidneys.
**Option B:** This option is incorrect because it does not accurately describe the location where xanthurenic acid is produced. While the kynurenine pathway is involved in tryptophan metabolism in the brain, xanthurenic acid is specifically produced in the liver and kidneys.
**Option C:** This option is incorrect because it does not provide a correct location for xanthurenic acid production. While the kynurenine pathway occurs in various tissues, xanthurenic acid is specifically produced in the liver and kidneys.
**Clinical Pearl / High-Yield Fact**
Xanthurenic acid is a known metabolite that can accumulate in the urine in individuals with certain genetic disorders, such as Hartnup disease, which affects the transport of tryptophan and other amino acids in the kidneys.
**Correct Answer: D. Liver**